To all our CKB CORE users, don’t miss the latest new features now available! Register for a free CORE account here and then login for access. Feel free to contact us at ckbsupport@genomenon.com if you have any questions!

Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT03771820
Title Combination Therapy With NC-6004 and Pembrolizumab in Head and Neck Cancer Subjects Who Have Failed Platinum Regimen
Recruitment Unknown status
Gender both
Phase Phase II
Variant Requirements No
Sponsors NanoCarrier Co., Ltd
Indications
Therapies
Age Groups: adult | senior
Covered Countries POL | HUN | HRV | CZE


No variant requirements are available.